```json
{
"content": [
{
"type": "paragraph",
"content": "North America currently dominates the Lectis (Carbohydrate Binding Proteins) market growth, accounting for 35% of global demand. Advanced biopharmaceutical infrastructure, high R&D investments from key players, and robust adoption in diagnostics and drug development drive its leadership. Regulatory frameworks like FDA approvals also accelerate innovation."
},
{
"type": "paragraph",
"content": "Europe follows with a 25% share, fueled by strong academic research ecosystems, EU Horizon funding for biotech, and rising demand in oncology and immunology applications. However, fragmented regulatory landscapes and slower commercialization pipelines moderate growth compared to North America."
},
{
"type": "paragraph",
"content": The Asia Pacific region is the fastest-growing market, projected to expand at a CAGR of 12% through 2030. Government initiatives in India and China to boost biomanufacturing, coupled with a rising burden of metabolic diseases, are critical drivers. Ecosystem maturity lags but is improving via cross-border partnerships.
},
{
"type": "paragraph",
"content": "Latin America and the Middle East & Africa collectively represent 10% of the regional forecast, with adoption constrained by limited infrastructure and underdeveloped supply chains. However, targeted investments in public health programs and diagnostic accessibility are creating emerging opportunities."
}
],
"worldMapData": {
"regions": [
{ "name": "North America", "value": 35 },
{ "name": "Europe", "value": 25 },
{ "name": "Asia Pacific", "value": 20 },
{ "name": "Latin America", "value": 10 },
{ "name": "Middle East & Africa", "value": 10 }
]
}
}
```
